OCUPHIRE PHARMA INC (OCUP)

US67577R1023 - Common Stock

1.64  +0.05 (+3.47%)

After market: 1.61 -0.03 (-1.83%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
19.05M39.85M590.00K0.000.00
Operating Expenses
29.61M21.62M23.29M9.46M11.21M
Research and Development
17.65M14.36M15.17M6.65M5.48M
Selling, General, and Administrative Expenses
11.96M7.27M8.12M2.82M5.73M
Operating Income
-10.56M18.23M-22.70M-9.46M-11.21M
Interest Income/Expense
-1.25M-10.00K-33.83M-8.33M2.58M
Other Income/Expense
1.84M-10.00K-160.00K10.00K0.00
Non Recurring Items
N/AN/A0.00-6.83M-10.00K
Income Before Taxes
-9.97M18.20M-56.69M-24.62M-8.64M
Income Tax
12.00K320.00K0.000.000.00
Net Income
-9.99M17.89M-56.69M-24.62M-8.64M
EBITDA
-10.56MN/AN/A-9.45M-11.17M
 
Per Share Data
EPS Diluted Total Ops
-0.460.87-3.82-5.28-8.72
Non GAAP EPS
-0.480.76-1.59-6.28-8.74
 
Statistics
Profit Margin
-52.42%44.89%-9608.47%N/AN/A
Operating Profit Margin
-55.45%45.75%-3847.46%N/AN/A

All data in USD

Charts